Other: pentadecanoic acid (pa) and triheptadecanoin (tha) (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 299 | 嚢胞性線維症 | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00572975 (ClinicalTrials.gov) | August 2006 | 11/12/2007 | Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea | MALABSORPTION BLOOD TEST: Toward a Novel Approach to Quantify Steatorrhea | Cystic Fibrosis;Pancreatic Insufficiency | Other: Pentadecanoic acid (PA) and Triheptadecanoin (THA) | Children's Hospital of Philadelphia | Solvay Pharmaceuticals | Completed | 8 Years | N/A | Both | 9 | Phase 4 | United States |